Key Takeaway: Global Genes is an organization dedicated to supporting patients affected by rare diseases. It aims to connect, empower, and inspire individuals and families navigating the challenges of rare conditions. The group provides a supportive community for those experiencing confusion and isolation due to their circumstances.
Price reaction · baseline $3.54 (2023-09-22T16:30:00.000Z) · hit during market hours · 19 other OVID headline(s) in the window, move may be shared
day 0 close · peak
+2.8%
Market Sentiment Analysis
POSITIVE FACTORS
Global Genes connects the rare disease community.
It empowers and inspires patients and their families.
The organization addresses feelings of isolation.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+622%
120-day peak, hindsight
Typical move
2.4%
average across 3 past catalysts
Cash runway
~33 mo
Minimal dilution risk
Full Press Release Details
Global Genes groups are the friends, family and supporters of the patients who are affected by rare disease. They understand the confusion, the overwhelming experience of the unknown and the feelings of isolation all too well. The reason Global Genes was born is to connect, empower and inspire the rare disease community.
Visit Site »
Frequently Asked Questions
What is Global Genes?
Global Genes is an organization supporting patients affected by rare diseases.
How does Global Genes help patients?
It connects, empowers, and inspires individuals and families in the rare disease community.
Why was Global Genes founded?
It was created to address confusion and isolation experienced by rare disease patients.
Biotech snapshot
Cash runway
$166M liquidity · $5M/mo burn
~33 mo
Minimal dilution risk
Catalyst track record
+622%
best trade around OVID's most recent catalyst
Peak hindsight return over a 120-day window, across 3 tracked FDA/PDUFA catalysts for OVID.